The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Nonsteroidal Anti-Inflammatory Drugs for the Prevention of Alzheimer’s Disease: A Systematic Review
Abstract
Objective: Alzheimer’s disease, the most prevalent dementia, is a prominent source of chronic illness in the elderly. Laboratory evidence suggests that nonsteroidal anti-inflammatory drugs (NSAIDs) might prevent the onset of Alzheimer’s disease. Since the early 1990s, numerous observational epidemiological studies have also investigated this possibility. The purpose of this meta-analysis is to summarize and evaluate available evidence regarding exposure to nonaspirin NSAIDs and risk of Alzheimer’s disease using meta-analyses of published studies. Methods: A systematic search was conducted using Medline, Biological Abstracts, and the Cochrane Library for publications from 1960 onwards. All cross-sectional, retrospective, or prospective observational studies of Alzheimer’s disease in relation to NSAID exposure were included in the analysis. At least 2 of 4 independent reviewers characterized each study by source of data and design, including method of classifying exposure and outcome, and evaluated the studies for eligibility. Discrepancies were resolved by consensus of all 4 reviewers. Results: Of 38 publications, 11 met the qualitative criteria for inclusion in the meta-analysis. For the 3 case-control and 4 cross-sectional studies, the combined risk estimate for development of Alzheimer’s disease was 0.51 (95% CI = 0.40–0.66) for NSAID exposure. In the prospective studies, the estimate was 0.74 (95% CI = 0.62–0.89) for the 4 studies reporting lifetime NSAID exposure and it was 0.42 (95% CI = 0.26–0.66) for the 3 studies reporting a duration of use of 2 or more years. Conclusions: Based on analysis of prospective and nonprospective studies, NSAID exposure was associated with decreased risk of Alzheimer’s disease. An issue that requires further exploration in future trials or observational studies is the temporal relationship between NSAID exposure and protection against Alzheimer’s disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease
Tang, M.-X., Jacobs, D., Stern, Y., Marder, K., Schofield, P., Gurland, B., Andrews, H., & Mayeux, R. (1996) · The Lancet · doi:10.1016/s0140-6736(96)03356-9 · Cited by 1,647
McGeer, P. L., Schulzer, M., & McGeer, E. G. (1996) · Neurology · doi:10.1212/wnl.47.2.425 · Cited by 1,367
Lindsay, J. (2002) · American Journal of Epidemiology · doi:10.1093/aje/kwf074 · Cited by 1,261
Nonsteroidal Antiinflammatory Drugs and the Risk of Alzheimer's Disease
in 't Veld, B. A., Ruitenberg, A., Hofman, A., Launer, L. J., van Duijn, C. M., Stijnen, T., Breteler, M. M. B., & Stricker, B. H. C. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010178 · Cited by 1,196
Risk of Alzheimer's disease and duration of NSAID use
Stewart, W. F., Kawas, C., Corrada, M., & Metter, E. J. (1997) · Neurology · doi:10.1212/wnl.48.3.626 · Cited by 1,132
Clinical trial of indomethacin in Alzheimer's disease
Rogers, J., Kirby, L. C., Hempelman, S. R., Berry, D. L., McGeer, P. L., Kaszniak, A. W., Zalinski, J., Cofield, M., Mansukhani, L., Willson, P., et al. (1993) · Neurology · doi:10.1212/wnl.43.8.1609 · Cited by 999
Kawas, C., Resnick, S., Morrison, A., Brookmeyer, R., Corrada, M., Zonderman, A., Bacal, C., Lingle, D. D., & Metter, E. (1997) · Neurology · doi:10.1212/wnl.48.6.1517 · Cited by 966
Zandi, P. P. (2002) · JAMA · doi:10.1001/jama.288.17.2123 · Cited by 906
Self-citationIntake of flavonoids and risk of dementia
Commenges, D., Scotet, V., Renaud, S., Jacqmin-Gadda, H., Barberger-Gateau, P., & Dartigues, J.-F. (2000) · European Journal of Epidemiology · doi:10.1023/a:1007614613771 · Cited by 634
Ioannidis, J. P. A. (1998) · JAMA · doi:10.1001/jama.279.4.281 · Cited by 632
SELKOE, D. J. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb05554.x · Cited by 630
Evans, D. A., Funkenstein, H. H., Albert, M., Scherr, P. A., Cook, N. R., Chown, M. J., Hebert, L. E., Hennekens, C. H., & Taylor, J. O. (1989) · PubMed · Cited by 599
Breitner, J. C. S., Gau, B. A., Welsh, K. A., Plassman, B. L., McDonald, W. M., Helms, M. J., & Anthony, J. C. (1994) · Neurology · doi:10.1212/wnl.44.2.227 · Cited by 568
Self-citationPrevalence of dementia and probable senile dementia of the Alzheimer type in the Framingham Study
Bachman, D. L., Wolf, P. A., Linn, R., Knoefel, J. E., CobbS, J., Belanger, A., D'Agostino, R. B., & White, L. R. (1992) · Neurology · doi:10.1212/wnl.42.1.115 · Cited by 527
Alzheimer's disease: A study of epidemiological aspects
Heyman, A., Wilkinson, W. E., Stafford, J. A., Helms, M. J., Sigmon, A. H., & Weinberg, T. (1984) · Annals of Neurology · doi:10.1002/ana.410150406 · Cited by 525
Wine consumption and dementia in the elderly: a prospective community study in the Bordeaux area.
Orgogozo, J. M., Dartigues, J. F., Lafont, S., Letenneur, L., Commenges, D., Salamon, R., Renaud, S., & Breteler, M. M. B. (1997) · PubMed · Cited by 523
Etminan, M., Gill, S., & Samii, A. (2003) · BMJ · doi:10.1136/bmj.327.7407.128 · Cited by 511
Breitner, J. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)00049-k · Cited by 466
Self-citationNonsteroidal anti-inflammatory drugs in Alzheimer's disease
Rich, J. B., Rasmusson, D. X., Folstein, M. F., Carson, K. A., Kawas, C., & Brandt, J. (1995) · Neurology · doi:10.1212/wnl.45.1.51 · Cited by 446
A case‐control study of Alzheimer's disease in Australia
Broe, G. A., Henderson, A. S., Creasey, H., McCusker, E., Korten, A. E., Jorm, A. F., Longley, W., & Anthony, J. C. (1990) · Neurology · doi:10.1212/wnl.40.11.1698 · Cited by 445
Anti-inflammatory drugs and Alzheimer disease
Mcgeer, P., Mcgeer, E., Rogers, J., & Sibley, J. (1990) · The Lancet · doi:10.1016/0140-6736(90)91101-f · Cited by 437
A double-blind, placebo-controlled trial of diclofenac/misoprostol in Alzheimer’s disease
Scharf, S., Mander, A., Ugoni, A., Vajda, F., & Christophidis, N. (1999) · Neurology · doi:10.1212/wnl.53.1.197 · Cited by 390
The amyloid precursor protein of Alzheimer's disease is released by human platelets.
Bush, A. I., Martins, R. N., Rumble, B., Moir, R., Fuller, S., Milward, E., Currie, J., Ames, D., Weidemann, A., & Fischer, P. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55493-4 · Cited by 326
Reduced incidence of AD with NSAID but not H2receptor antagonists: The Cache County Study
Zandi, P. P., Anthony, J. C., Hayden, K. M., Mehta, K., Mayer, L., & Breitner, J. C. S. (2002) · Neurology · doi:10.1212/wnl.59.6.880 · Cited by 316
Self-citationAndersen, K., Launer, L. J., Ott, A., Hoes, A. W., Breteler, M. M. B., & Hofman, A. (1995) · Neurology · doi:10.1212/wnl.45.8.1441 · Cited by 285
Apolipoprotein E allele ∈4, dementia, and cognitive decline in a population sample
Henderson, A. S., Jorm, A. F., Korten, A. E., Christensen, H., Jacomb, P. A., Easteal, S., Croft, L., & Mackinnon, A. J. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92405-1 · Cited by 272
A CASE-CONTROL STUDY OF DEMENTIA OF THE ALZHEIMER TYPE
FRENCH, L. R., SCHUMAN, L. M., MORTIMER, J. A., HUTTON, J. T., BOATMAN, R. A., & CHRISTIANS, B. (1985) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a114013 · Cited by 244
Nonsteroidal anti-inflammatory drug use and Alzheimer-type pathology in aging
Mackenzie, I. R. A., & Munoz, D. G. (1998) · Neurology · doi:10.1212/wnl.50.4.986 · Cited by 244
A case‐control study of Alzheimer's disease
Graves, A. B., White, E., Koepsell, T. D., Reifler, B. V., Van Belle, G., Larson, E. B., & Raskind, M. (1990) · Annals of Neurology · doi:10.1002/ana.410280607 · Cited by 237
The epidemiology of estrogen replacement therapy and Alzheimer's disease
Henderson, V. W. (1997) · Neurology · doi:10.1212/wnl.48.5_suppl_7.27s · Cited by 225
Reduced prevalence of AD in users of NSAIDs and H2 receptor antagonists: The Cache County Study
Anthony, J. C., Breitner, J. C. S., Zandi, P. P., Meyer, M. R., Jurasova, I., Norton, M. C., & Stone, S. V. (2000) · Neurology · doi:10.1212/wnl.54.11.2066 · Cited by 224
Self-citationBreteler, M. M. B., Van Duijn, C. M., Chandra, V, Fratiglioni, L., Graves, A. B., Heyman, A., Jorm, A. F., Kokmen, E., Kondo, K., Mortimer, J. A., et al. (1991) · International Journal of Epidemiology · doi:10.1093/ije/20.supplement_2.s36 · Cited by 181
Anti-inflammatory Drugs Protect Against Alzheimer Disease at Low Doses
Broe, G. A., Grayson, D. A., Creasey, H. M., Waite, L. M., Casey, B. J., Bennett, H. P., Brooks, W. S., & Halliday, G. M. (2000) · Archives of Neurology · doi:10.1001/archneur.57.11.1586 · Cited by 160
Microglia and the Immune Pathology of Alzheimer Disease
Giulian, D. (1999) · The American Journal of Human Genetics · doi:10.1086/302477 · Cited by 148
NSAIDs and incident Alzheimer’s disease. The Rotterdam study
In ’t Veld, B. A., Launer, L. J., Hoes, A. W., Ott, A., Hofman, A., Breteler, M. M. B., & Stricker, B. H. C. (1998) · Neurobiology of Aging · doi:10.1016/s0197-4580(98)00096-7 · Cited by 145
Rheumatold Arthritis and Senile Dementia of the Alzhelmer's Type
Jenkinson, M. L., Bliss, M. R., BRAIN, A. T., & Scott, D. L. (1989) · Lara D. Veeken · doi:10.1093/rheumatology/28.1.86-b · Cited by 143
Ibuprofen protects dopaminergic neurons against glutamate toxicity in vitro
Casper, D., Yaparpalvi, U., Rempel, N., & Werner, P. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01294-5 · Cited by 138
Beard, C. M., Waring, S. C., O'Brien, P. C., Kurland, L. T., & Kokmen, E. (1998) · Mayo Clinic Proceedings · doi:10.4065/73.10.951 · Cited by 114
Do NSAIDs prevent Alzheimer's disease? And, if so, why? The epidemiological evidence
Zandi, P. P., & Breitner, J. C. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00297-4 · Cited by 108
Self-citationMcGeer, P. L., Harada, N., Kimura, H., McGeer, E. G., & Schulzer, M. (1992) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000107010 · Cited by 105
A case‐control study of Alzheimer's disease in China
Li, G., Shen, Y., Li, Y. T., Chen, C. H., Zhau, Y. W., & Silverman, J. M. (1992) · Neurology · doi:10.1212/wnl.42.8.1481 · Cited by 104
Brookmeyer, R., & Gray, S. (2000) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(20000615/30)19:11/12<1481::aid-sim440>3.0.co;2-u · Cited by 83
Alzheimer's Disease and Rheumatoid Arthritis
Myllykangas-Luosujärvi, R., & Isomäki, H. A. (1994) · Lara D. Veeken · doi:10.1093/rheumatology/33.5.501 · Cited by 82
Clock Drawing: Analysis in a Retirement Community
Paganini‐Hill, A., Clark, L. J., Henderson, V. W., & Birge, S. J. (2001) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2001.49185.x · Cited by 82
Epidemiology of Dementia in Rochester, Minnesota
Kokmen, E., Beard, C. M., O’Brien, P. C., & Kurland, L. T. (1996) · Mayo Clinic Proceedings · doi:10.4065/71.3.275 · Cited by 80
Inflammation and Alzheimer's disease
Jones, R. W. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05667-7 · Cited by 79
Nonsteroidal antiinflammatory drug use in Alzheimer's disease
Lucca, U., Tettamanti, M., Forloni, G., & Spagnoli, A. (1994) · Biological Psychiatry · doi:10.1016/0006-3223(94)90598-3 · Cited by 75
Effect of Anti-inflammatory Medications on Neuropathological Findings in Alzheimer Disease
Halliday, G. M., Shepherd, C. E., McCann, H., Reid, W. G. J., Grayson, D. A., Broe, G. A., & Kril, J. J. (2000) · Archives of Neurology · doi:10.1001/archneur.57.6.831 · Cited by 72
Double placebo design in a prevention trial for Alzheimer's disease
Martin, B. K., Meinert, C. L., & Breitner, J. C. S. (2002) · Controlled Clinical Trials · doi:10.1016/s0197-2456(01)00189-1 · Cited by 71
Self-citationAspirin, anti-inflammatory drugs and risk of dementia.
Henderson, A. S., Jorm, A. F., Christensen, H. M., Jacomb, P. A., & Korten, A. E. (1997) · PubMed · Cited by 68
Do Nonsteroidal Antiinflammatory Drugs Reduce the Risk of Alzheimer's Disease?
Breitner, J. C. S., & Zandi, P. P. (2001) · New England Journal of Medicine · doi:10.1056/nejm200111223452110 · Cited by 67
Self-citationLandi, F., Cesari, M., Onder, G., Russo, A., Torre, S., & Bernabei, R. (2003) · American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200303000-00008 · Cited by 58
Fourrier, A., Letenneur, L., Bégaud, B., & Dartigues, J. (1996) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(96)00202-8 · Cited by 43
Rheumatoid arthritis and susceptibility to Alzheimer's disease
Beard, C. M., KOKMAN, E., & Kurland, L. (1991) · The Lancet · doi:10.1016/0140-6736(91)93122-p · Cited by 35
Wolfson, C. M., Perrault, A., Moride, Y., Esdaile, J. M., Abenhaim, L., & Momoli, F. (2002) · Neuroepidemiology · doi:10.1159/000048621 · Cited by 27
Risk of Alzheimer's disease and duration of NSAID use
Delanty, N., & Vaughan, C. J. (1998) · Neurology · doi:10.1212/wnl.51.2.652 · Cited by 23
Do Nonsteroidal Anti-Inflammatory Drugs Have a Protective Effect Against Dementia?
Muiswinkel, F. L. V., & Eikelenboom, P. (1996) · Drugs & Aging · doi:10.2165/00002512-199609010-00001 · Cited by 17
Neuroepidemiology of vascular and Alzheimer's dementia among African-American women.
Harris, Y., Gorelick, P. B., Freels, S. A., Billingsley, M., Brown, N. P., & Robinson, D. J. (1995) · PubMed · Cited by 10
New epidemiologic strategies in Alzheimer's disease may provide clues to prevention and cause
Breitner, J. C. S. (1994) · Neurobiology of Aging · doi:10.1016/0197-4580(94)90199-6 · Cited by 10
Self-citationAisen, P. S., Schafer, K. A., Grundman, M., Pfeiffer, E., Sano, M., Davis, K. L., Farlow, M. R., Jin, S., Thomas, R. G., Thal, L. J., et al. (2003) · JAMA · doi:10.1001/jama.289.21.2819 · Cited by 5
Nonsteroidal anti‐inflammatory drugs in Alzheimer's disease
Haruda, F. D. (1995) · Neurology · doi:10.1212/wnl.45.11.2116 · Cited by 4
Cited by
Inflammatory processes in Alzheimer's disease
Heneka, M. T., & O'Banion, M. K. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.11.017 · Cited by 782
The role of interleukin-1 in neuroinflammation and Alzheimer disease: an evolving perspective
Shaftel, S. S., Griffin, W. S. T., & O'Banion, M. K. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-7 · Cited by 565
Inflammation and the Degenerative Diseases of Aging
McGEER, P. L., & McGEER, E. G. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1332.007 · Cited by 518
NSAIDs and Alzheimer disease: Epidemiological, animal model and clinical studies
McGeer, P. L., & McGeer, E. G. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.03.013 · Cited by 498
Role of toll-like receptor signalling in A uptake and clearance
Tahara, K., Kim, H.-D., Jin, J.-J., Maxwell, J. A., Li, L., & Fukuchi, K.-I. (2006) · Brain · doi:10.1093/brain/awl249 · Cited by 493
“(McGeer et al., 1990; Breitner et al., 1994; Breitner et al., 1995; Stewart et al., 1997; Veld et al., 2000; Szekely et al., 2004).”
Metadata
- Authors
- Szekely, C. A., Thorne, J. E., Zandi, P. P., Ek, M., Messias, E., Breitner, J. C. S., & Goodman, S. N.
- Venue
- Neuroepidemiology
- Publisher
- S. Karger AG
- Published
- 2004
- Volume
- 23
- Issue
- 4
- Pages
- 159-169
- ISSN
- 0251-5350 (ISSN-L)
- 1423-0208
- OpenAlex
- W1994925004
- Cited by
- 397
- References
- 63
- FWCI
- 2.56
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.